Comparing two antibiotics to prevent C. diff in IBD patients
Treatments studied
Part of Digestive system, Infections clinical trials.
This study compares two medicines, fidaxomicin and vancomycin, to see which one is better at preventing C. diff infection in people with inflammatory bowel disease who are having a colonoscopy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have Crohn’s disease, ulcerative colitis, or indeterminate colitis.
- You are scheduled for an outpatient colonoscopy.
- You have not had your colon removed, a colostomy, or other colon surgery (except appendix removal).
- You are not currently taking antibiotics for another infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether xylitol can help “decolonize” (reduce colonization of) C. difficile germs in people with inflammatory bowel disease (IBD). It may help lower the chance of C. diff becoming a problem, but it is mainly a safety/timing early study.
This trial tests if xylitol, a natural sugar substitute, can reduce the amount of C. difficile bacteria in the gut of people with inflammatory bowel disease (IBD) who are in remission or have mild symptoms. If successful, it might help prevent future C. diff infections.
This trial compares three treatments for Clostridioides difficile infection (a severe diarrhea caused by bacteria) to see which works best and prevents it from coming back. It tests a fecal microbiota transplant (FMT, transferring healthy donor stool), fidaxomicin, and vancomycin, all given by mouth or tube.
This trial tests whether taking vancomycin by mouth can prevent another C. diff infection when you need to take other antibiotics. It’s for patients who recently had C. diff and are about to start a new antibiotic course.
This study tests whether taking a capsule form of fecal microbiota transplant (FMT) can help adults with their first C. difficile infection—or a first relapse—get better and reduce repeat episodes. Participants also take specific antibiotics for C. difficile as part of the study process.
This trial tests whether adding a bile acid supplement (ursodeoxycholic acid) to standard antibiotics can help prevent a repeat C. diff infection. It is for people who have already had a C. diff infection and have at least one factor that increases their risk of it coming back.
Hear when a new Clostridioides Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.